Frequently Asked Questions

Get answers to common questions about Semaglutide 1.25mg (Weekly injections X 4).

Many patients notice appetite reduction and initial weight changes within two to four weeks, with more substantial results over time. The four-week 1.25mg protocol is designed to accelerate progress while monitoring tolerance and efficacy closely.

Common side effects include nausea, mild gastrointestinal upset, and temporary appetite changes. These symptoms often diminish with time; our clinicians provide dosing guidance, anti-nausea strategies, and support to manage side effects during treatment.

Good candidates are adults experiencing difficulty losing weight despite lifestyle efforts, who meet medical criteria. We evaluate medical history, medications, and health markers to confirm that the 1.25mg four-week course is appropriate and safe.

After an in-clinic demonstration and assessment, many patients safely self-administer weekly injections at home. We teach proper technique, storage, and disposal, and schedule follow-up to ensure correct administration and address concerns.

Semaglutide can interact with medications affecting blood sugar or gastric motility. Provide a complete medication list; our clinicians review interactions, adjust plans as needed, and monitor safety throughout the four-week treatment period.

This four-week boost helps overcome plateaus and refine progress. After the protocol, we review results, adjust maintenance or dosing strategies, and recommend lifestyle, follow-up, and longer-term plans to support sustainable weight goals.